Rab7A is required for efficient production of infectious HIV-1
about
The restriction factors of human immunodeficiency virusTetherin can restrict cell-free and cell-cell transmission of HIV from primary macrophages to T cells.A Genetic Screen Identifies a Critical Role for the WDR81-WDR91 Complex in the Trafficking and Degradation of Tetherin.Characterization of E3 ligases involved in lysosomal sorting of the HIV-1 restriction factor BST2.HIV-1 enhances mTORC1 activity and repositions lysosomes to the periphery by co-opting Rag GTPases.An siRNA screen of membrane trafficking genes highlights pathways common to HIV-1 and M-PMV virus assembly and releaseA cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction.Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophagesRab6 dependent post-Golgi trafficking of HSV1 envelope proteins to sites of virus envelopment.HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins.The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapyFilamin A Is Involved in HIV-1 Vpu-mediated Evasion of Host Restriction by Modulating Tetherin Expression.ATP1B3 Protein Modulates the Restriction of HIV-1 Production and Nuclear Factor κ Light Chain Enhancer of Activated B Cells (NF-κB) Activation by BST-2.The frantic play of the concealed HIV envelope cytoplasmic tail.A comparative mutational analysis of HIV-1 Vpu subtypes B and C for the identification of determinants required to counteract BST-2/Tetherin and enhance viral egress.The ubiquitin-conjugating system: multiple roles in viral replication and infection.Mechanisms underlying HIV-1 Vpu-mediated viral egress.Profiling of Host Cell Response to Successive Canine Parvovirus Infection Based on Kinetic Proteomic Change Identification.Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2.Viral Interactions with Host Cell Rab GTPases.Endocytic tubules regulated by Rab GTPases 5 and 11 are used for envelopment of herpes simplex virus.Molecular Events in Late Stages of HIV-1 Replication.Elucidating the in vivo interactome of HIV-1 RNA by hybridization capture and mass spectrometry.Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution.
P2860
Q24605108-379CCFED-E26D-4E54-A27B-477F4A89C8DEQ31172123-11E8FE02-5D7E-4EF7-8606-9EBC215F942FQ33292303-995A5951-613C-4BE4-8464-D331931CE565Q33743176-E6AE3259-5719-4162-A134-48172D721CA1Q33905696-4BD18CB3-0A3C-445D-ADAB-D9EB54CE2758Q34134636-CBA17758-B9E2-4B92-86A7-C7DF45EBC207Q34220959-E3BE21BB-7A8D-40BF-9401-60B9B6217A7BQ35016131-9FD4D019-DF3D-496B-951C-2AF18FD3DE9DQ35024610-C8C833D9-3A19-4DD7-816E-982FD6EFE969Q35895988-033BF72F-1303-4A68-B0A7-4E59C499D329Q36505647-C2A1B547-FF70-4664-AD43-85268F0134DBQ36594734-C1C6FC78-21B0-4D8F-AB91-A049F92AF9B4Q36744586-2D95077F-01A7-49DC-82AC-8ABB93AFA126Q36940646-E947942E-636F-43B4-AB32-07AAA7C48572Q37141248-1EABAFE6-FE21-427B-94F4-C3FF48AEACA9Q38210024-A69FC91E-126E-4E77-9A2F-149FC3E732B1Q38211428-F4BD4A14-0923-49CB-80BA-6332643F138BQ38444908-0BCAFA78-2B57-4784-99B4-2F36C872AB61Q39014592-EC406A67-E933-4D4A-A74E-3CEB60E84877Q39428496-09ED04C5-E86A-45DF-A49D-0E0279D83F2FQ41360930-C7911E16-4842-44E7-8B40-4856E29F14A7Q41692107-710B124D-5C04-4FB8-8843-D1B9F602B788Q47094347-A448FBA6-89D9-4FC8-A843-970927D4DAD2Q47095093-13216BAA-E58D-4D06-9B92-8E8786AF20C6
P2860
Rab7A is required for efficient production of infectious HIV-1
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Rab7A is required for efficient production of infectious HIV-1
@ast
Rab7A is required for efficient production of infectious HIV-1
@en
Rab7A is required for efficient production of infectious HIV-1
@en-gb
Rab7A is required for efficient production of infectious HIV-1
@nl
type
label
Rab7A is required for efficient production of infectious HIV-1
@ast
Rab7A is required for efficient production of infectious HIV-1
@en
Rab7A is required for efficient production of infectious HIV-1
@en-gb
Rab7A is required for efficient production of infectious HIV-1
@nl
prefLabel
Rab7A is required for efficient production of infectious HIV-1
@ast
Rab7A is required for efficient production of infectious HIV-1
@en
Rab7A is required for efficient production of infectious HIV-1
@en-gb
Rab7A is required for efficient production of infectious HIV-1
@nl
P2093
P2860
P3181
P1433
P1476
Rab7A is required for efficient production of infectious HIV-1
@en
P2093
Annegret Pelchen-Matthews
Clarisse Berlioz-Torrent
Delphine Delcroix-Genête
Grégory Camus
Marina Caillet
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1002347
P407
P577
2011-11-01T00:00:00Z